Compile Data Set for Download or QSAR
maximum 50k data
Found 503 Enz. Inhib. hit(s) with all data for entry = 6893
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156741(US9029559, 161)
Affinity DataIC50:  29.4nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156793(US9029559, 222)
Affinity DataIC50:  37nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156839(US9029559, 271)
Affinity DataIC50:  41.8nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157019(US9029559, 466)
Affinity DataIC50:  46.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156883(US9029559, 320)
Affinity DataIC50:  48.4nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156995(US9029559, 438)
Affinity DataIC50:  49.1nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156726(US9029559, 142)
Affinity DataIC50:  50nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157040(US9029559, 493)
Affinity DataIC50:  50.6nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM47277(BDB47277 | US9029559, 289)
Affinity DataIC50:  52.8nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157001(US9029559, 446)
Affinity DataIC50:  57.1nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157118(US9029559, 602)
Affinity DataIC50:  62.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157044(US9029559, 497)
Affinity DataIC50:  67.8nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156752(US9029559, 178)
Affinity DataIC50:  68.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156782(US9029559, 209)
Affinity DataIC50:  69.6nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156727(US9029559, 143)
Affinity DataIC50:  73.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156865(US9029559, 301)
Affinity DataIC50:  73.7nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156892(US9029559, 330)
Affinity DataIC50:  75.1nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157119(US9029559, 603)
Affinity DataIC50:  80.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156884(US9029559, 322)
Affinity DataIC50:  81.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156763(US9029559, 190)
Affinity DataIC50:  81.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156830(US9029559, 262)
Affinity DataIC50:  81.9nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156917(US9029559, 355)
Affinity DataIC50:  83.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157062(US9029559, 515)
Affinity DataIC50:  87.1nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156813(US9029559, 244)
Affinity DataIC50:  90.1nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156788(US9029559, 217)
Affinity DataIC50:  90.2nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156743(US9029559, 165)
Affinity DataIC50:  94.4nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157022(US9029559, 472)
Affinity DataIC50:  96nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157017(US9029559, 464)
Affinity DataIC50:  99.3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156789(US9029559, 218)
Affinity DataIC50:  99.8nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156836(US9029559, 268)
Affinity DataIC50:  102nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157108(US9029559, 588)
Affinity DataIC50:  107nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157010(US9029559, 457)
Affinity DataIC50:  107nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157013(US9029559, 460)
Affinity DataIC50:  107nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157027(US9029559, 477)
Affinity DataIC50:  110nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157002(US9029559, 447)
Affinity DataIC50:  111nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156799(US9029559, 230)
Affinity DataIC50:  111nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156849(US9029559, 281)
Affinity DataIC50:  114nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM47349(US9029559, 482)
Affinity DataIC50:  115nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156985(US9029559, 428)
Affinity DataIC50:  116nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM47345(US9029559, 470)
Affinity DataIC50:  118nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156769(US9029559, 196)
Affinity DataIC50:  119nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156890(US9029559, 328)
Affinity DataIC50:  119nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157009(US9029559, 456)
Affinity DataIC50:  119nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156846(US9029559, 278)
Affinity DataIC50:  120nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM47332(US9029559, 366)
Affinity DataIC50:  121nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156661(US9029559, 1)
Affinity DataIC50:  123nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156738(US9029559, 158)
Affinity DataIC50:  126nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156686(US9029559, 37)
Affinity DataIC50:  130nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM157037(US9029559, 489)
Affinity DataIC50:  131nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM156930(US9029559, 369)
Affinity DataIC50:  132nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 503 total ) | Next | Last >>
Jump to: